Investigating the epidemiology of medication errors in adults in community care settings

References

1. ↵
   1. DiPiro JT TR,
   2. Yee GC,
   3. Matzke GR,
   4. Wells BG,
   5. Posey L

   1. Mark S,
   2. Little J,
   3. Geller S,
   4. Weber R

   (2011) in Pharmacotherapy:A Pathophysiologic Approach, Principles and Practices of Medication Safety, eds DiPiro JT TR, Yee GC, Matzke GR, Wells BG, Posey L (McGraw-Hill, New York (NY)).
2. ↵
   1. World Health Organization

   (2016) Medication Errors:Technical Series on Safer Primary Care (World Health Organization, Geneva (CN)) Available from: http://apps.who.int/iris/bitstream/10665/252274/1/9789241511643-eng.pdf.
3. ↵
   1. Assiri GA,
   2. Shebl NA,
   3. Mahmoud MA,
   4. Aloudah N,
   5. Grant E,
   6. Aljadhey H,
   7. et al.

   (2018) What is the epidemiology of medication errors, error-related adverse events and risk factors for errors in adults managed in community care contexts?A systematic review of the international literature. BMJ Open 8(5):e019101.

   OpenUrlAbstract/FREE Full Text
4. ↵
   1. Avery AJ,
   2. Rodgers S,
   3. Cantrill JA,
   4. Armstrong S,
   5. Cresswell K,
   6. Eden M,
   7. et al.

   (2012) A pharmacist-led information technology intervention for medication errors (PINCER):a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis. The Lancet 379(9823):1310–1319.

   OpenUrl
5. ↵
   1. Saudi Food and Drug Authority

   Registered Drugs and Herbal Products List, Available from: http://www.sfda.gov.sa/en/drug/search/Pages/default.aspx. [cited 2017].
6. ↵
   1. The University of Nottingham

   Evidence-Based Summaries for Health Foundation. PINCER 2015, Available from: https://www.nottingham.ac.uk/primis/tools-audits/tools-audits/pincer/pincer.aspx. [Update 2018 July].
7. ↵
   1. Avery AJ,
   2. Rodgers S,
   3. Cantrill JA,
   4. Armstrong S,
   5. Elliott R,
   6. Howard R,
   7. et al.

   (2009) Protocol for the PINCER trial:a cluster randomised trial comparing the effectiveness of a pharmacist-led IT-based intervention with simple feedback in reducing rates of clinically important errors in medicines management in general practices. Trials 10:28.

   OpenUrlCrossRefPubMed
8. ↵
   1. Kimberlin CL,
   2. Winterstein AG

   (2008) Validity and reliability of measurement instruments used in research. American Society of Health-System Pharmacists 65:2276–2284.

   OpenUrl
9. ↵
   1. McHugh ML

   (2012) Interrater reliability:the kappa statistic. Biochemia Medica 22:276–282.

   OpenUrl
10. ↵
    1. Pannucci CJ,
    2. Wilkins EG

    (2010) Identifying and avoiding bias in research. Plast Reconstr Surg 126:619–625.

    OpenUrlCrossRefPubMed
11. ↵
    1. Brink PJ,
    2. Wood MJ

    1. Lackey NR,
    2. Wingate AL

    (1998) in Advanced Design in Nursing Research, The pilot study:one key to research success, eds Brink PJ, Wood MJ (Sage, Thousand Oaks (CA)).
12. ↵
    1. Tache SV,
    2. Sonnichsen A,
    3. Ashcroft DM

    (2011) Prevalence of adverse drug events in ambulatory care:a systematic review. Ann Pharmacother 45:977–989.

    OpenUrlCrossRefPubMed
13. ↵
    (2014) A Dictionary of Epidemiology (Oxford University Press, New York (NY)), 6th ed.
14. ↵
    1. Landis JR,
    2. Koh GG

    (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174.

    OpenUrlCrossRefPubMedWeb of Science
15. ↵
    1. Vandenbroucke JP,
    2. von Elm E,
    3. Altman DG,
    4. Gøtzsche PC,
    5. Mulrow CD,
    6. Pocock SJ,
    7. et al.

    (2007) Strengthening the Reporting of Observational Studies in Epidemiology (STROBE):Explanation and Elaboration. PLoS Medicine 4:e297.

    OpenUrl
16. ↵
    1. Benchimol EI,
    2. Smeeth L,
    3. Guttmann A,
    4. Harron K,
    5. Moher D,
    6. Petersen I,
    7. et al.

    (2015) The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Medicine 12:e1001885.

    OpenUrl
17. ↵
    1. Howard RL,
    2. Avery AJ,
    3. Slavenburg S,
    4. Royal S,
    5. Pipe G,
    6. Lucassen P,
    7. et al.

    (2007) Which drugs cause preventable admissions to hospital?A systematic review. Br J Clin Pharmacol 63:136–147.

    OpenUrlCrossRefPubMedWeb of Science
18. 1. Howard RL,
    2. Avery AJ,
    3. Howard PD,
    4. Partridge M

    (2003) Investigation into the reasons for preventable drug related admissions to a medical admissions unit:observational study. Quality and Safety in Health Care 12:280–285.

    OpenUrlAbstract/FREE Full Text
19. ↵
    1. Chen YF,
    2. Avery AJ,
    3. Neil KE,
    4. Johnson C,
    5. Dewey ME,
    6. Stockley IH

    (2005) Incidence and possible causes of prescribing potentially hazardous/contraindicated drug combinations in general practice. Drug Safety 28:67–80.

    OpenUrlCrossRefPubMedWeb of Science
20. ↵
    1. Avery AJ,
    2. Rodgers S,
    3. Cantrill JA,
    4. Armstrong S,
    5. Boyd M,
    6. Cresswell K,
    7. et al.

    (2010) PINCER trial:a cluster randomised trial comparing the effectiveness and cost-effectiveness of a pharmacist-led IT based intervention with simple feedback in reducing rates of clinically important errors in medicines management in general practices. Patient Safety Research Portfolio. Birmingham:Department of Health.
21. ↵
    1. Hippisley-Cox J,
    2. Pringle M,
    3. Cater R,
    4. Wynn A,
    5. Hammersley V,
    6. Coupland C,
    7. et al.

    (2003) The electronic patient record in primary care-regression or progression?A cross sectional study. BMJ 326:1439–1443.

    OpenUrlAbstract/FREE Full Text
22. ↵
    1. Akbarov A,
    2. Kontopantelis E,
    3. Sperrin M,
    4. Stocks SJ,
    5. Williams R,
    6. Rodgers S,
    7. et al.

    (2015) Primary Care Medication Safety Surveillance with Integrated Primary and Secondary Care Electronic Health Records:A Cross-Sectional Study. Drug Safety 38:671–682.

    OpenUrlCrossRefPubMed